Eton CFO reports 37,000 stock options
Rhea-AI Filing Summary
Eton Pharmaceuticals, Inc. Chief Financial Officer Judith M. Matthews filed an initial Form 3 disclosing beneficial ownership of an employee stock option linked to 37,000 shares of common stock at an exercise price of $26.05 per share, expiring on April 12, 2036.
According to the disclosure, these employee stock options will vest in four equal installments on April 13 of 2027, 2028, 2029 and 2030, and are held directly by Matthews.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Matthews Judith M.
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Employee Stock Option | -- | -- | -- |
Holdings After Transaction:
Employee Stock Option — 37,000 contracts (Direct)
Footnotes (1)
- F1. The Employee Stock Options will vest in four equal installments on April 13, 2027, 2028, 2029 and 2030.
Key Figures
Underlying shares: 37,000 shares
Exercise price: $26.05 per share
Option expiration: April 12, 2036
+2 more
5 metrics
Underlying shares
37,000 shares
Employee stock option underlying Eton common stock
Exercise price
$26.05 per share
Exercise price of employee stock option
Option expiration
April 12, 2036
Expiration date of employee stock option
Post-report option position
37,000 underlying shares
Total shares covered following reported holding
Vesting schedule
4 equal installments 2027–2030
Options vest April 13 of 2027, 2028, 2029, 2030
Key Terms
Employee Stock Option, Form 3, beneficial ownership, vesting
4 terms
Employee Stock Option financial
"The Employee Stock Options will vest in four equal installments on April 13, 2027, 2028, 2029 and 2030."
An employee stock option is a promise that lets a worker buy company shares later at a predetermined price, often after they stay for a certain period or meet performance goals — think of it like a coupon that locks in today's price for a future purchase. It matters to investors because options align employees’ incentives with company performance, can increase the number of shares outstanding (dilution) when exercised, and represent a compensation cost that affects reported profits and shareholder value.
Form 3 regulatory
"Chief Financial Officer Judith M. Matthews filed an initial Form 3 disclosing beneficial ownership"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
beneficial ownership financial
"filed an initial Form 3 disclosing beneficial ownership of an employee stock option"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
vesting financial
"The Employee Stock Options will vest in four equal installments on April 13, 2027, 2028, 2029 and 2030."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the ETON Form 3 filed by CFO Judith M. Matthews report?
The Form 3 reports Judith M. Matthews’ beneficial ownership of an employee stock option covering 37,000 shares of Eton Pharmaceuticals common stock, with an exercise price of $26.05 and an expiration date of April 12, 2036, held in her direct ownership.
What is the exercise price and expiration date of the ETON CFO’s stock option?
The employee stock option reported by Eton’s CFO has an exercise price of $26.05 per share and an expiration date of April 12, 2036. These terms define the price and time window during which the option can potentially be exercised under the plan.
How do the ETON CFO’s employee stock options vest over time?
The employee stock options vest in four equal installments on April 13, 2027, April 13, 2028, April 13, 2029, and April 13, 2030. This staggered vesting schedule means portions of the 37,000 underlying shares become exercisable gradually over several years.
Is the ETON CFO’s reported stock option held directly or indirectly?
The Form 3 shows the employee stock option is held directly by the CFO. The ownership code is listed as direct, with no indication of a trust, partnership, or other entity, meaning the reported beneficial ownership is attributed personally to Judith M. Matthews.
Does the ETON Form 3 show any stock purchases or sales by the CFO?
The Form 3 does not report any stock purchases or sales. It discloses a holding of an employee stock option covering 37,000 underlying shares, with the transaction data characterized as a holding entry rather than a buy, sell, exercise, or disposition event.
AI-generated analysis. How Rhea-AI works. Not financial advice.
